Diabetes and cardiovascular disease

Diabetes Care

Volumn 22, Issue SUPPL. 3, 1999, Pages

  Sowers, James R ^a   Lester, Melvin A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; LOW DENSITY LIPOPROTEIN; METFORMIN; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN; TROGLITAZONE; VON WILLEBRAND FACTOR;

ATHEROSCLEROSIS; BLOOD CLOTTING DISORDER; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DIABETIC NEPHROPATHY; DYSLIPIDEMIA; GLOMERULOSCLEROSIS; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; THROMBOCYTE ANOMALY; VASCULAR ENDOTHELIUM;

ARTERIOSCLEROSIS; BLOOD COAGULATION DISORDERS; BLOOD PLATELET DISORDERS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERINSULINISM; MALE; RISK FACTORS;

EID: 0032912811     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (96)

1. Stearns S, Schlesingh MJ, Rudy A: Incidence and clinical significance of coronary artery disease in diabetes mellitus. Arch Intern Med 80:463-474, 1947
2. Pyorala K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1:131-146, 1979
3. Eschwege E, Richard JL, Thibult N: Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels: the Paris Prospective Study, ten years later. Horm Metab Res 15:41-46, 1985
4. Walsh MF, Dominguez LJ, Sowers JR: Metabolic abnormalities in cardiac ischemia. Cardiol Clinics 13:529-538, 1995
5. Hargreaves AD, Logan RL, Elton RA, Buchanan KD, Oliver MF, Riemersmaa RA: Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12 year follow-up and development of coronary heart disease in Edinburgh men. Atherosclerosis 94:61-69, 1992
6. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703-713, 1998
7. Stein B, Weintraub WS, Gebhart S: Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 91:979-989, 1995
8. Sowers JR: Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 158:617-621, 1998
9. The National High Blood Pressure Education Program Working Group: National high blood pressure education program working group report on hypertension in diabetes. Hypertension 23:145-158, 1994
10. Grais IM, McLean B, Prisant LM, Ryan WM, Saunders E, Schoenberger JA, Sowers JR, Sugimoto DH, Weir MR, Smith H, Miller AJ, Messerli F, Vertes V: A proposal for an amplified staging system for hypertension: JNC VI. Arch Intern Med 156:1938-1947, 1997
11. Landin D, Krotkiewski M, Smith U: Importance of obesity for the metabolic abnormalities associated with an abdominal fat distribution. Metabolism 38:572-576, 1989
12. Jensen M, Haymond M, Rizza R, Cryer P. Moles J: Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 83:1168-1173, 1989
13. Dowse GK, Zimmet PZ, Gareeboo H: Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose intolerance in Indian, Creole, and Chinese Mauritians. Diabetes Care 14:271-282, 1991
14. Colditz GA, Willet WC, Rotsnitzky A, Manson JE: Weight gain as a nsk factor for clinical diabetes in women. Ann Intern Med 122:481-486, 1995
15. Sowers JR: Modest weight gain and the development of diabetes: another perspective. Ann Intern Med 122:548-549, 1995
16. Ferraro RT, Eckel RH, Larson DE, Fontvielle AM, Rising R, Jensen DR, Ravussin E: Relationship between skeletal muscle lipoprotein lipase activity and 24-hour macronutrient oxidation. J Clin Invest 92:441-445, 1993
17. Frayn KN, Coppack SW, Fielding BA, Humphreys SM: Coordinated regulation of hormone-sensitive lipase and lipoprotein lipase in human adipose tissue in vivo: Implications for the control of fat storage and fat mobilization. Adv Enzyme Regul 35:163-178, 1995
18. Tchernof A, Lamarche M, Prud'Homme MD: The dense LDL phenotype: association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 19:629-637, 1996
19. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwège E:. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia 34:356-361, 1991
20. Ferrara LA, Mancini M, Celentano A, Galderisi M, Iannuzi R, Marotta T, Gaeta I: Early changes of the arterial carotid wall in hyperinsulmemia, hypertriglyceridemia versus hypercholesterolemia. Arterioscler Thromb 13:367-370, 1993
21. Sowers JR, Sowers PS, Peuler JD: Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis. J Lab Clin Med 123:647-652, 1994
22. Folsom AR, Eckfeldt JH, Weitzman S, Ma J, Chambless LE, Barnes RW, Cram KB, Hutchinson RG: Atherosclerosis Risk in Communities (ARIC) Study Investigators: relation of carotid artery wall thickness in diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke 25:66-73, 1994
23. Salomaa V, Riley W, Kaark JD, Nardo C, Folsom AR: Non-insulin dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness index: the ARIC study. Circulation 91:1432-1443, 1995
24. Agewall S, Fagerberg B, Attvall S, Wendelhag I, Urbanavicius V, Wikstrand J: Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke 26:956-960, 1995
25. Desprès J-P, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien P-J: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957, 1996
26. Shinozaki K, Naritomi H, Shimizu T, Suzuki M, Ikebuchi M, Sawada T, Harano Y: Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke 27:37-43, 1996
27. Pan DA, Lillioja S, Milner MR: Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J Clin Invest 96:2802-2808, 1995
28. Borkman M, Storlein LH, Pan DA: The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. N Engl J Med 328:238-244, 1995
29. Poehlman ET, Toth MJ, Bunyard LB: Physiological predictors of increasing total and central adiposity in aging men and women. Arch Intern Med 155:2443-2448, 1995
30. Bakris GL, Palant CE, Walsh MF, Sowers JR: Analogy between endothelial/mesangial cell and endothelial/vascular smooth muscle cell interactions: role of growth factors and mechanotransduction. In Endocrinology of the Vasculature. Sowers JR, Ed. Totowa, NJ, Humana Press, p. 341-355, 1996
31. King GL, Goodman AD, Buzney S, Moses A: Receptors and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 75:1028-1036, 1985
32. Sowers JR: Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 29:691-699, 1997
33. Bornfeldt KE, Skottner A, Amquist HJ: In vivo regulation of messenger RNA encoding insulin-like growth factor 1 (IGF-1) and its receptor by diabetes, insulin and IGF-1 in rat muscle. J Endocrinol 135:203-211, 1992
34. Reiss K, Kajstura J, Capasso JM, Marino TA, Anversa P: Impairment of myocyte contractility following coronary artery narrowing is associated with activation of the myocyte IGF-1 autocinre system, enhanced expression of late growth related genes, DNA synthesis, and myocyte nuclear mitotic diversion in rats. Exp Cell Res 207:348-360, 1993
35. Sowers JR: Effects of insulin and IGF-1 on vascular smooth muscle glucose and cation metabolism. Diabetes 45:47-51, 1996
36. García Frade LJ, de la Calle H, Alava I, Navarro JL, Creight LJ, Gaffney LJ: Diabetes mellitus as an hypercoagulable state: its relationship with fibrin fragments and vascular damage. Thromb Res 47:533-540, 1987
37. Ford I, Singh TP, Kitchen S, Makris M, Ward JD, Preston FE: Activation of coagulation in diabetes mellitus in relation to the presence of vascular complications. Diabet Med 8:322-329, 1991
38. Carmassi F, Morale M, Puccetti R: Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. Thromb Res 67:643-654, 1992
39. 1 and fasting serum glucose in young diabetic women. Diabetes Care 3:655-658, 1980
40. Ramirez LC, Arauz-Pacheco C, Lackner C: Lipoprotein (a) levels in diabetes mellitus: relationship to metabolic control. Ann Intern Med 117:42-47, 1992
41. Ceriello A, Quatraro A, Dello Russo P: Protein C deficiency in insulin dependent diabetes: a hyperglycemia-related phenomenon. Thromb Haemost 64:104-107, 1990
42. Vukovich TC, Proidl S, Knobl P, Teufelsbauer H, Schnack C, Schernthaner G: The effect of insulin treatment on the balance between tissue plasminogen activator and plasminogen activator inhibitor-1 in type 2 diabetic patients. Throm Haemost 68:253-256, 1992
43. Stein JH, Rosenson RS: Lipoprotein Lp(a) excess and coronary heart disease. Arch Intern Med 157:1170-1176, 1997
44. Winocour PD, Bryszewska M, Watula C: Reduced membrane fluidity in platelets from diabetic patients. Diabetes 39:241-244, 1990
45. Davi G, Catalons I, Averna M: Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 322:1768-1774, 1990
46. Standley PR, Ali S, Bapna C, Sowers JR: Increased platelet cytosolic calcium responses to low density lipoprotem in type II diabetes with and without hypertension. Am J Hypertens 938-943, 1993
47. Levy J, Gavin JR III, Sowers JR: Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med 96:260-270, 1994
48. Fakuda K, Ozaki Y, Satoh K, Kume S: Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation. Diabetes 46:488-493, 1997
49. Sampretro T, Lenzi S, Cicchetti P: Nonenzymatic glycation of human platelet membrane proteins in vitro and in vivo. Clin Chem 32:1328-1331, 1986
50. Sowers JR, Epstein M: Risk factors for arterial disease in diabetes: hypertension. In Diabetic Angiopathy. Tooke JE, Ed. London, U.K., Arnold Publishers, 1999, p. 45-63
51. Tribe RM, Poston L: Oxidative stress and lipids in diabetes: a role in endothelial vasodilator function? Vasc Med 1:195-206, 1996
52. McMillen DE: Development of vascular complications in diabetes. Vasc Med 2:132-142, 1997
53. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H: Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci U S A 90:6434-6438, 1993
54. Yan SD, Schmidt AM, Anderson J: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269:9989-9997, 1994
55. Baumgartner-Parzer SM, Wagner L, Pettermann M, Gessel A, Waldhäusi W: Modulation by high glucose of adhesion molecule expression in cultured endothelial cells. Diabetologia 38:1367-1370, 1995
56. Tesfamariam B, Brown ML, Cohen RA: Elevated glucose impaired endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 87:1643-1648, 1991
57. Rattan V, Sultana C, Shen Y, Kaba VK: Oxidant stress-induced transendothelial migration of monocytes is linked to phosphorylation of PECAM-1. Am J Physiol 273:E453-E461, 1997
58. Tooke JE: Microvascular function in human diabetes. Diabetes 44:721-726, 1995
59. Paston L, Taylor PD: Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Circulation Res 88:245-255, 1995
60. Cagliero E, Roth T, Roy S, Lorenzi M: Characteristics and mechanisms of high-glucose-induced over-expression of basement membrane components in cultured human endothelial cells. Diabetes 40:102-110, 1991
61. Garcia MJ, McNamara PM, Gordon T, Kannel WB: Morbidity and mortality in diabetics in the Framingham population: sixteen-year follow-up study. Diabetes Care 13:631-654, 1990
62. Barrett-Connor E, Cohn BA, Wingard DL, Edelstein SL: Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? JAMA 265:627-631, 1991
63. USRDS 1995 Annual Data Report: incidence and causes of treated ESRD. Am J Kidney Dis 26:S39-S50, 1995
64. Goldberg RJ, Larson M, Levy D: Factors associated with survival to 75 years of age in middle-aged men and women: the Framingham Study. Arch Intern Med 156:505-509, 1996
65. Albert C: Sex differences in cardiac arrest survivors. Circulation 93:1170-1176, 1996
66. Hanes DS, Weir MR, Sowers JR: Gender considerations in hypertension pathophysiology and treatment. Am J Med 101 (Suppl. 3A):10S-21S, 1996
67. Lissner L, Bengtsson C, Lapidus L, Kristjansson K, Wedel H: Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension 20:797-801, 1992
68. Peuler JD, Johnson BAB, Sowers JR: Sex specific effects of an insulin secretagogue in stroke prone hypertensive rats. Hypertension 22:214-220, 1993
69. Skafar DF, Xu R, Morales J, Ram J, Sowers JR: Female sex hormones and cardiovascular disease in women. J Clin Endocrinol Metab 82:3913-3918, 1997
70. Bell DSH: Diabetic cardiomyopathy: a unique entity or a complication of coronary artery disease? Diabetes Care 18:708-714, 1995
71. Ren J, Davidoff AJ: Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. Am J Physiol 272:H148-H158, 1997
72. Ren J, Dominguez LJ, Sowers JR, Davidoff AJ: Troglitazone attenuates high-glucose-induced abnormalities in relaxation and intracellular calcium in rat ventricular myocytes. Diabetes 45:1822-1825, 1996
73. Oswald G, Cororan S, Yudkin J: Prevalence and risks of hyperglycemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet 11:1264-1267, 1984
74. Leor J, Goldbourt U, Reicher-Reiss H, Kuplinsky E, Beher S: Cardiogenic shock complicating acute myocardial infarction in patients without hean failure on admission: incidence risk factors and outcome. Am J Med 94:265-273, 1993
75. Vik-Mo H, Mjos O: Influence of free fatty acids on myocardial oxygen consumption and ischemic injury. Am J Cardiol 48:361-365, 1981
76. Chavers BM, Bilous RW, Ellis EN, Steffes MW, Mauer SM: Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med 320:966-970, 1989
77. Shultz PJ, Schorer AE, Raij L: Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells. Am J Physiol 258:F162-F167, 1990
78. Bakris GL, Fairbanks R, Traish AM: Arginine vasopressin stimulates human mesangial cell production of endothelin. J Clin Invest 87:1158-1164, 1991
79. Sowers JR, Epstein M: Diabetes mellitus and hypertension: emerging therapeutic perspectives. Cardiovasc Drug Rev 13:149-210, 1995
80. Zhang F, Sowers JR, Ram JL, Standley PR, Peuler JD: Effects of pioglitazone on L-type calcium channels in vascular smooth muscle. Hypertension 24:170-175, 1994
81. 2+ currents and not endothelial nitric oxide production. Diabetes 46:659-664, 1997
82. Dominguez LJ, Davidoff AJ, Srinivas PR, Standley PR, Walsh MF, Sowers JR: Effects of metformin on tyrosine kinase activity, glucose transport, and intracellular calcium in rat vascular smooth muscle. Endocrinology 137:113-121, 1996
83. Ruiz J, Blanche H, Cohen N: Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin dependent diabetes mellitus. Proc Natl Acad Sci U S A 91:3662-2665, 1994
84. Schunkert H, Hense HW, Holmer SR: Association between deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 330:1634-1638, 1994
85. Doria A, Warram JH, Krolewski AS: Genetic predisposition to diabetic nephropathy: evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 43:690-695, 1994
86. Berk BC, Duff JL, Marrero MB, Bernstein KE: Angiotensin II signal transduction in vascular smooth muscle. In Endocrinology of the Vasculature. Sowers JR, Ed. Totowa, NJ, Humana Press, 1996, p. 187-204
87. Eggena P, Barren JD: The vascular renin system. In Endocrinology of the Vasculature2E Sowers JR, Ed. Totowa, NJ, Humana Press, 1996, p. 205-214
88. Meyer TW, Anderson S, Rennke HG, Brenner BM: Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int 31:752-759, 1987
89. Ravid M, Savin H, Jutrin I, Rental T, Katz B, Lishner M: Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in noemotensive type II diabetic patients. Ann Intern Med 118:577-581, 1993
90. Expen Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Summary of the second report on the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Cholesterol in Adults (Adult Treatment Panel II). JAMA 269:3015-3023, 1993
91. Bakris GL, Weir MR, Sowers JR: Therapeutic challenges in the obese diabetic patient with hypertension. Am J Med 101:33S-46S, 1996
92. Babey AV, Gebicki JM, Sullivan DR, Willey K: Increased oxidizability of plasma lipoproteins in diabetic patients can be prevented by probacal therapy and is not due to glycation. Biochem Pharm 43:995-1000, 1992
93. Paolisso G, Balbi V, Volpe C: Metabolic benefits derived from chronic vitamin supplementation in aged non-insulin dependent diabetics. J Am Coll Nutr 14:387-392, 1995
94. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA: Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 97:22-28, 1996
95. Reaven PD, Herold DA, Barnett J, Edelmann S: Effects of vitamin E on susceptibility of low-density lipoprotein and subfractions to oxidation and on protein glycation in NIDDM. Diabetes Care 18:807-816, 1995
96. Scala Moy C, Laporte R, Dorman J: Insulin dependent diabetes mellitus mortality: the risks of cigarette smoking. Circulation 82:37-43, 1990